📰 Rna News
Page 27 - Rna News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rna. Real-time updates on events, politics, business and more.
May 27, 2023
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) have been given an average recommendation of “Buy” by the seven research firms that are currently covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 […]
May 26, 2023
Evercore ISI upgraded shares of Avidity Biosciences (NASDAQ:RNA – Get Rating) from an in-line rating to an outperform rating in a research note issued to investors on Monday, The Fly reports. They currently have $20.00 price target on the biotechnology company’s stock. Several other research analysts also recently issued reports on RNA. Credit Suisse Group […]
May 25, 2023
Evaxion developed a genetic adjuvant technology that boosts the immune responses of viral, bacterial and cancer vaccinesPreclinically validated for both DNA and mRNA vaccines, and ready for clinical testing
May 24, 2023
GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024 ... | May 24, 2023
May 23, 2023
Florida health officials deleted key data and statistics from a state analysis on the safety of mRNA COVID-19 vaccines, falsely making them appear unsafe for yo
May 23, 2023
Moderna is investing $322 million to open a biomanufacturing facility in Marlborough, Mass. in September 2024.
May 22, 2023
Moderna has reported interim phase 1/2 data for mRNA-3927, its mRNA therapy targeted at propionic acidemia (PA).
May 22, 2023
Shares of Twist Bioscience Corporation (TWST) are gaining 11% on Monday morning trade, after the company launched a portfolio of RNA sequencing tools. Twist is currently trading at $14.
May 20, 2023
Artisan Partners Limited Partnership grew its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) by 232.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,300,976 shares of the biotechnology company’s stock after purchasing an additional 910,048 shares during the period. […]
May 19, 2023
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacementTo date, mRNA-3927 has been generally well-tolerated at the doses administered, with encouraging early